Trial intelligence / Profile preview

Oral Contraceptives in the Metabolic Syndrome

NCT00205504Phase 4Completed

Sponsor
Virginia Commonwealth University
Start
Jun 2005
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of norgestimate + ethinyl estradiol, sponsored by Virginia Commonwealth University. Started Jun 2005; status: completed.

02

Drugs

norgestimate + ethinyl estradiol

Beyond the preview

Go deeper on NCT00205504.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00205504.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call